Le Lézard
Classified in: Health, Business
Subject: PER

Houston-Based SynBio VC firm Adds Retired Circuit City CEO to Advisory Group

HOUSTON, Sept. 26, 2022 /PRNewswire/ -- Today, First Bight Ventures, a Houston-based venture firm that focuses exclusively on the advancement and acceleration of early-stage Synthetic Biology companies, announced that it has added Alan McCollough to its growing panel of expert advisors. McCollough served as chairman and chief executive officer of Circuit City Stores Inc. and has decades of proven operating experience with consumer-driven public entities. He recently retired from the boards of VF Corporation and Goodyear Corporation.

"We are excited to have Alan join our group of advisors given his deep consumer and retail experience. He has vast knowledge of industrial companies that will offer valuable counsel to our portfolio companies. We hope to leverage his background so that our startups can select appropriate commercialization paths for their business models," First Bight Founder Veronica Wu said.

"I believe in the potential of Biotech to address many of the challenges facing our planet today. I hope to bring some of my experience to support innovative startups within the space," McCollough said.

McCollough joins First Bight's advisors who represent a variety of companies and industries, including Solugen, a specialty chemicals manufacturer; Proxima Clinical Research, Inc., which helps emerging companies overcome regulatory and clinical obstacles to get their medical products approved; Oracle Cloud, which offers cloud computing services; and DTE Energy, which develops and manages energy-related businesses and services nationwide.

"Our plan, in bringing Alan on as a key advisor, is to accelerate our overall investment activity, especially given the fact that the Bioeconomy is a critical factor for addressing global sustainability. President Biden's recent pledge of over $2B in Biomanufacturing will help encourage more research, innovation, and commercialization as it relates to consumer products. This includes more plant- and bio-based materials, as well as drug manufacturing, such as vaccine production," Wu added.

More about First Bight can be found on the company's website at firstbight.com.

SOURCE First Bight Ventures

These press releases may also interest you

at 08:15
Endologix LLC, a privately held global medical device company, dedicated to improving patients' lives with innovative interventional treatments for vascular disease, today announced that it has received U.S. Food and Drug Administration (FDA)...

at 08:15
The World Economic Forum, the world's foremost international organization for public-private cooperation, has named U.S.-based medical technology company Xenco Medical the winner of its 2022 New Champions Award for Excellence in Sustainable Growth....

at 08:10
Generate Biomedicines today announced that Jane Mendillo has been appointed to its board of directors. Ms. Mendillo brings impressive investment and financing expertise to the machine-learning-powered biotech. "As Generate approaches the early...

at 08:10
Masimo today announced the full market release of Hydration Index (Hitm) for the Masimo W1tm watch. The Masimo W1, an advanced health tracking wearable, is the first watch to offer accurate, continuous pulse oximetry measurements and insightful...

at 08:05
Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced key appointments across clinical affairs, marketing, and operations...

at 08:05
Ankyra Therapeutics, a biotech company developing targeted immune activating agents for the treatment of cancer, today announced that Leisha A. Emens, M.D., Ph.D., has been appointed as senior vice president, translational research. Dr. Emens is an...

News published on 26 september 2022 at 15:47 and distributed by: